The procurement of cells for the derivation of human embryonic stem cell lines for therapeutic use: recommendations for good practice.
The donation of human embryos for the derivation of embryonic stem cell lines that may be used in the development of therapeutic products raises more complex ethical, practical and regulatory problems than the donation of embryos for non-clinical research. This review considers these issues and offers recommendations for good practice.